Drug Resistant Superbugs Pose Great Threat to Public Health as New Antibiotic Development Stalls
Drug resistant “superbugs” pose an increasingly big threat to the our ability to treat a variety of bacterial infections. However, very few new antibiotics have been produced in recent years because of economic factors such as their lower profitability for pharmaceutical companies and low medicare reimbursements. Adam Woodrow, President of the biotech company Paratek, say that “we’ll have to see some form of legislation to enable drug companies to survive in this environment.” If this trend continues, more and more treatments that were once routine will be rendered unreliable. Antibiotic resistant infections are responsible for killing one person every 15 minutes.
Full Story: CBS News